Government - MM+M - Medical Marketing and Media

Government

All articles by Government

Drug pricing doesn’t make the Families Plan cut
Drug pricing doesn’t make the Families Plan cut
Lecia Bushak
May 3, 2021
11:45 am

But given its popularity on both sides of the aisle, pricing reform will remain top of mind.

As the supply/demand curves bend
As the supply/demand curves bend
Lecia Bushak
April 22, 2021
4:57 pm

With supply of COVID-19 vaccines poised to exceed demand within weeks, states pivot to address hesitancy of remaining Americans.

Inside the puzzling delay in naming a new FDA commissioner
Inside the puzzling delay in naming a new FDA commissioner
Lecia Bushak
April 14, 2021
4:45 pm

Without a permanent leader, the FDA’s public-health priorities could be imperiled.

Why marketing and communication will play a crucial role in Biden’s extended ACA enrollment period
Why marketing and communication will play a crucial role in Biden’s extended ACA enrollment period
Lecia Bushak
February 17, 2021
5:05 pm

The extra three months represent an opportunity to persuade as well as to educate.

Biden wants equitable distribution of vaccines, but there’s a long way to go
Biden wants equitable distribution of vaccines, but there’s a long way to go
Lecia Bushak
February 3, 2021
4:42 pm

State and local groups can – and should – be a large part of the bigger push.

Five things for pharma marketers to know: Tuesday, February 2, 2021
Five things for pharma marketers to know: Tuesday, February 2, 2021
Lecia Bushak
February 2, 2021
5:00 am

FDA’s delay on aducanumab prompts questions; Horizon buys Viela Bio for $3 billion; EU imposes COVID-19 vaccine export controls.

Five things for pharma marketers to know: Monday, February 1, 2021
Five things for pharma marketers to know: Monday, February 1, 2021
Lecia Bushak
February 1, 2021
5:00 am

Novavax vaccine effective but weaker in South Africa variant; FDA delays decision on Biogen’s Alzheimer’s drug; data collection challenges during COVID-19.

Five things for pharma marketers to know: Friday, January 29, 2021
Five things for pharma marketers to know: Friday, January 29, 2021
Lecia Bushak
January 29, 2021
5:00 am

Biden signs executive orders on healthcare; Amgen’s cancer drug effective in shrinking lung tumors; EU prods AstraZeneca to send vaccine supplies to mainland Europe.

Five things for pharma marketers to know: Thursday, January 28, 2021
Five things for pharma marketers to know: Thursday, January 28, 2021
Lecia Bushak
January 28, 2021
5:00 am

Coalition urges using opioid settlement funds to help people with substance abuse issues; ATAI Life Sciences and Mass General to study psychedelics for mental health; drug-resistant infections surge in hospitals

Five things for pharma marketers to know: Wednesday, January 27, 2021
Five things for pharma marketers to know: Wednesday, January 27, 2021
Lecia Bushak
January 27, 2021
5:00 am

Federal government to boost vaccine allocations to states; Regeneron says its monoclonal antibody prevents COVID-19; FTC sues Endo and Impax over opioid.

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners